Budesonide Market 2020 and Forecast 2021-2027

                                          
Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohns disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.

The industrys leading manufacturers are AstraZeneca and Teva, with 52.93% and 16.78% of revenue, respectively. By region, North America has the highest share of income, at around 36.5% in 2019.

Market Analysis and Insights: Global Budesonide Market


The global Budesonide market size is projected to reach US$ 9809.2 million by 2026, from US$ 8073 million in 2020, at a CAGR of 3.3% during 2021-2026.

Global Budesonide Scope and Segment

Budesonide market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Budesonide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.

The following manufacturers are covered in this report:

 	
AstraZeneca
 	
Teva
 	
Mylan
 	
Sandoz
 	
Cosmo Pharmaceuticals
 	
Salix
 	
Chiesi Farmaceutici
 	
Orion Corporation
 	
Cipla
 	
Synmosa Biopharma
 	
Lunan Better Pharma
 	
Shanghai Sine Promod

Budesonide Breakdown Data by Type

 	
Injectable Suspension
 	
Aerosols
 	
Inhalation Powder
 	
Tablet and Capsule

Budesonide Breakdown Data by Application

 	
Respiratory Disease Treatment
 	
Nose Disease Treatment
 	
Inflammatory Bowel Disease Treatment
 	
Others

Regional and Country-level Analysis

The Budesonide market is analysed and market size information is provided by regions (countries).
The key regions covered in the Budesonide market report are North America, Europe, China, Israel, Taiwan (China) and India. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.

Competitive Landscape and Budesonide Market Share Analysis
This research comprehensively answers the following 9 important questions:

 	
Q.1. What are some of the most promising growth trends in the Budesonide market worldwide?
 	
Q.2.Which segments and sub-segments will grow at a faster pace and why? Which segment is nearing the peak and demand saturation?
 	
Q.3.Which region will witness a higher growth rate and why? Which region might see a slower or negative growth region?
 	
Q.4.What are the key factors affecting market dynamics? What are the drivers, challenges, and business risks in Budesonide market?
 	
Q.5.What are the business risks and who pose challenges to the global leaders and are competitive threats in this Budesonide market?
 	
Q.6.What are the emerging trends post COVID-19 reshuffle in this Budesonide market and the what are reasons behind these trends and do they translate in global exploration?
 	
Q.7. Who are the major global and regional players in the Budesonide market? Which are the strategic initiatives key players are pursuing for business growth?
 	
Q.8.Which are the competing products in Budesonide market and how big of a threat do they pose for loss of market share by material or product substitution?
 	
Q.9.What M & A activity has occurred in the last 5 years and what is its impact on the Budesonide industry?